Today’s guest post comes from Mark Thierer, Chief Executive Officer of EVERSANA. Mark explains how combining direct-to-patient and direct-to-payer strategies can improve transparency, streamline access, and better align key stakeholders. He introduces EVERSANA DIRECT, the company’s new approach to market access. To learn more, visit eversana.com/DIRECT. Read on for Mark’s insights. Read more »© 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute, an HMP Global Company. All righ...
